|
Avience Biomedicals Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
136.03 Cr.
|
P/BV
|
6.19
|
Book Value (Rs.)
|
40.07
|
|
52 Week High/Low (Rs.)
|
415/222
|
FV/ML
|
10/600
|
P/E(X)
|
20.20
|
|
Bookclosure
|
|
EPS (Rs.)
|
12.28
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 |
| | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 12.47 | 9.80 | 2.95 |
| | | | |
| Net CashFlow From Operating Activities | 5.91 | 3.61 | 0.99 |
| Net Cash Used In Investing Activities | -13.27 | -8.81 | -4.03 |
| Net Cash Used From Financing Activities | 5.42 | 9.25 | 2.97 |
| Adjustments On Amalgamation / Merger / Demerger And Others | 0.00 | 0.00 | 0.13 |
| | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -1.95 | 4.05 | 0.05 |
| Cash And Cash Equivalents Begin of Year | 4.22 | 0.15 | 0.09 |
| Cash And Cash Equivalents End Of Year | 2.27 | 4.20 | 0.15 |
